DeuteRx Employee Directory
Biotechnology ResearchNew Hampshire, United States2-10 Employees
DeuteRx is a biotechnology research company that uses deuterium-enabled chiral switching to develop differentiated new chemical entities with patent-protected compositions. This approach is intended to support an expedited and derisked development path for new therapeutics. The company cites a record of four M&A transactions, a Phase 2b NASH drug candidate (PXL065) developed with Poxel SA, and discoveries involving molecular glue degraders, backed by a portfolio of over 50 issued patents. Based in Bedford, New Hampshire, the organization operates with a small team. In January 2022, Salarius Pharmaceuticals entered an agreement to acquire an oral, small-molecule targeted protein degradation portfolio from DeuteRx.